Search

everythinglearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The treatment combination is effective and generally safe for lung cancer.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Scalp cryotherapy significantly reduces hair loss during and shortly after chemotherapy.

Oral minoxidil may effectively treat hair loss from chemotherapy.

Resveratrol-loaded carriers may help reduce hair loss from chemotherapy when used with scalp cooling.

PLD is an effective and safer alternative for treating breast cancer.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Chemotherapy can harm kidneys in breast cancer patients.

The new nanoparticles could improve melanoma treatment by working better than current options.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Image analysis can effectively identify changes in scalps affected by chemotherapy-induced hair loss.

Some breast cancer chemotherapy can cause permanent hair loss.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.